Shanghai, China — Ekhbary News Agency
Chinese surgeons successfully implanted a brain-computer interface (BCI) in a patient suffering from limited hand mobility this Monday at a Shanghai hospital. This procedure marks the world's first commercial application of an approved non-invasive device of its kind, representing a significant leap in medical technology. The patient, who sustained a spinal cord injury a decade ago in a car accident, had experienced limited hand function despite extensive rehabilitation efforts. During the operation, a coin-sized implant was carefully placed on the surface of the patient’s brain, designed to restore limb function.
Pioneering Non-Invasive Technology
The device, known as NEO, was developed by the innovative Chinese startup Neuracle. Following its approval by China's medical regulator in March, it has now transitioned from rigorous clinical trials to commercial hospital use, a pivotal moment for the company. Officials confirmed the operation proceeded smoothly and exactly as planned, with the patient currently recovering well and vital signs reported as stable. Crucially, the implant immediately and effectively captured stable, high-quality brain signals, indicating its successful integration and functionality. For what it's worth, this advancement truly underscores China's growing prowess in cutting-edge medical innovation.
Read Also
- England Star Marc Guehi Slams 'Negative Approach' After World Cup Exit
- British Illegal Immigrant Shot Dead in US Amid $70,000 Construction Scam Dispute
- Transgender Ex-Labour Candidate Charged Over Posts Following Ann Widdecombe's Death
- Postman Filmed Kicking Blind Shih Tzu to Death, Investigation Underway
- UK Government Rules Out Mandatory In-Car Breathalyser Hardware
Outpacing Global Competitors
This achievement places Neuracle firmly ahead of Elon Musk’s Neuralink in the global race to commercialize implantable brain-computer interfaces. While Neuralink has also conducted human chip implants and reports 21 participants in worldwide trials, it still awaits crucial full commercial approval in the United States. NEO's distinct non-invasive approach involves placing the chip on the brain's surface without penetrating it, contrasting sharply with Neuralink's method of inserting ultra-thin threads directly into brain tissue with the aid of a surgical robot. Other prominent firms like Synchron, which developed an implant inserted through a vein, and Meta, working on AI systems for non-invasive brain scans, are also exploring less invasive BCI routes, highlighting a broader industry trend towards safer, more accessible solutions for patients.
